|
Match
|
Document |
Document Title |
|
|
US20100304978 |
Methods and compositions for identifying a fetal cell
The present invention provides methods and compositions for specifically identifying a fetal cell. An initial screening of approximately 400 candidate genes by digital PCR in different fetal and... |
|
|
US20110020800 |
Characterization of BBK07 antigen of Borrelia burgdorferi and methods of use
In this application is described the characterization Borrelia burgdorferi lipoprotein BBK07, an in vivo expressed and surface-exposed immunogen. BBK07 expression in the infected hose can be... |
|
|
US20060166219 |
NTRK1 genetic markers associated with progression of Alzheimer's disease
Haplotypes in the NTRK1 gene associated with progression of Alzheimer's Disease are disclosed. Compositions and methods for detecting these NTRK1 haplotypes are disclosed. |
|
|
US20050255492 |
CHRNA9 genetic markers associated with progression of Alzheimer's disease
Haplotypes in the CHRNA9 gene associated with progression of Alzheimer's Disease are disclosed. Compositions and methods for detecting these CHRNA9 haplotypes are disclosed. |
|
|
US20050250122 |
APOA4 genetic markers associated with progression of Alzheimer's disease
Haplotypes in the APOA4 gene associated with progression of Alzheimer's Disease are disclosed. Compositions and methods for detecting these APOA4 haplotypes are disclosed. |
|
|
US20050250121 |
NTRK2 genetic markers associated with progression of Alzheimer's disease
Haplotypes in the NTRK2 gene associated with progression of Alzheimer's Disease are disclosed. Compositions and methods for detecting these NTRK2 haplotypes are disclosed. |
|
|
US20100166783 |
METHOD
Gene expression profiles, microarrays comprising nucleic acid sequences representing gene expression profiles, and new diagnostic kits and methods are provided. The gene expression profiles,... |
|
|
US20090264779 |
PREDICTING RISK OF MAJOR ADVERSE CARDIAC EVENTS
Measurement of circulating ST2 and natriuretic peptide (e.g., NT-proBNP) concentrations is useful for the prognostic evaluation of subjects, in particular for the prediction of adverse clinical... |
|
|
US20110092446 |
COMPOSITIONS AND METHODS FOR TREATMENT OF TRAUMA
The present invention features the use of a complement inhibitor, e.g., a compstatin analog for treating an individual who has suffered a severe injury. In some embodiments, the complement... |
|
|
US20060141460 |
Assays for fprl-1 ligands
Assays for screening for compounds that act as agonists, antagonists, or inverse agonists of CKβ8-1 at the FPRL-1 receptor. |
|
|
US20070077555 |
Adsorption system for the removal of viruses and viral components from fluids, in particular blood and blood plasma
The present invention relates to an adsorption system for the removal of viruses and viral components, in particular hepatitis C viruses, from physiological fluids, in particular whole blood or... |
|
|
US20070134690 |
Diagnosis of systemic onset juvenile idiopathic arthritis through blood leukocyte microarray analysis
The present invention includes compositions, systems and methods for the early detection and consistent determination of systemic onset juvenile idiopathic arthritis (SoJIA) using microarrays. |
|
|
US20100203530 |
Systems for genome selection
Systems, methods, compositions and apparatus relating to genome selection are disclosed. |
|
|
US20100062444 |
TLE3 AS A MARKER FOR CHEMOTHERAPY
Methods of using TLE3 as a marker for predicting the likelihood that a patient's cancer will respond to chemotherapy. Methods of using TLE3 as a marker for selecting a chemotherapy for a cancer. |
|
|
US20100166880 |
Method for treatment and diagnosis of glutamate dehydrogenase disorders
Methods and compositions for diagnosis and treatment of neurodegenerative disorders are disclosed. The methods and compositions apply the discovery of the correlation between an hGDH2 gene... |
|
|
US20050112649 |
Sensitive and self-calibrating multi-test system the detection and identification of enterohemorrhagic escherichia coli (EHEC)
We propose a novel high sensitivity multi-test detection and identification system for EHEC. The integrated testing system uses, in a single run, multiple molecular signatures and receptor... |
|
|
US20090215053 |
Vitro Method for the Prognosis of Progression of a Cancer and of the Outcome in a Patient and Means for Performing Said Method
The present invention relates to the prognosis of the outcome of a cancer in a patient, which prognosis is based on the quantification of one or several biological markers that are indicative of... |
|
|
US20110064721 |
CATHEPSIN-D NEUROPROTECTION
Provided herein are methods and compositions for promoting neuroprotection in a subject and for treating a neural disorder associated with protein aggregation comprising administering to the... |
|
|
US20050196773 |
Predicting upper aerodigestive tract cancer
Cancer screening models based on analysis of mass spectroscopy data can be used to predict upper aerodigestive tract cancer, including lung and head and neck cancers. Models can be generated by... |
|
|
US20060177821 |
Association of the h2 haplotype of the p2y12 receptor with an increased risk for thrombosis and peripheral arterial disease
The invention relates to an in vitro method for determining the risk of developing thrombosis in a subject, and to an in vitro method for determining sensitivity of a subject toward a... |
|
|
US20100190172 |
GENETIC POLYMORPHISMS ASSOCIATED WITH CARDIOVASCULAR DISORDERS AND DRUG RESPONSE, METHODS OF DETECTION AND USES THEREOF
The present invention is based on the discovery of genetic polymorphisms that are associated with cardiovascular disorders, particularly acute coronary events such as myocardial infarction and... |
|
|
US20110059447 |
METHOD FOR THE DETECTION OF GENE TRANSCRIPTS IN BLOOD AND USES THEREOF
The present invention is directed to detection and measurement of gene transcripts in blood. Specifically provided is a RT-PCR analysis performed on a drop of blood for detecting, diagnosing and... |
|
|
US20110008780 |
METHOD FOR THE DETECTION OF GENE TRANSCRIPTS IN BLOOD AND USES THEREOF
The present invention is directed to detection and measurement of gene transcripts in blood. Specifically provided is a RT-PCR analysis performed on a drop of blood for detecting, diagnosing and... |
|
|
US20110003298 |
METHOD FOR THE DETECTION OF GENE TRANSCRIPTS IN BLOOD AND USES THEREOF
The present invention is directed to detection and measurement of gene transcripts in blood. Specifically provided is a RT-PCR analysis performed on a drop of blood for detecting, diagnosing and... |
|
|
US20110003297 |
METHOD FOR THE DETECTION OF GENE TRANSCRIPTS IN BLOOD AND USES THEREOF
The present invention is directed to detection and measurement of gene transcripts in blood. Specifically provided is a RT-PCR analysis performed on a drop of blood for detecting, diagnosing and... |
|
|
US20110003296 |
Method for the detection of gene transcripts in blood and uses thereof
The present invention is directed to detection and measurement of gene transcripts in blood. Specifically provided is a RT-PCR analysis performed on a drop of blood for detecting, diagnosing and... |
|
|
US20110033858 |
siRNA DETECTION METHOD
PolydG is added to the terminal overhangs of an siRNA. Next, a primer containing a polydC sequence added with a tag sequence is annealed and cDNA is synthesized by a reverse transcription... |
|
|
US20090311684 |
ENHANCED FC RECEPTOR-MEDIATED TUMOR NECROSIS FACTOR SUPERFAMILY AND CHEMOKINE MRNA EXPRESSION IN PERIPHERAL BLOOD LEUKOCYTES IN PATIENTS WITH RHEUMATOID ARTHRITIS
A method for predicting patient responsiveness to rheumatoid arthritis treatments involving altering expression of TNFSF-3, TNFSF-4, TNFSF-7, TNFSF-11, or TNFSF-14 is disclosed. A method for... |
|
|
US20070042368 |
Detection and monitoring of lung cancer
Compositions and methods for the diagnosis of lung cancer are disclosed. Such methods are useful to detect early tumors or provide adequate stage/grade information or tumor specificity.... |
|
|
US20090035279 |
GENETIC VARIANTS ON CHR 15Q24 AS MARKERS FOR USE IN DIAGNOSIS, PROGNOSIS AND TREATMENT OF EXFOLIATION SYNDROME AND GLAUCOMA
The present invention relates to methods of diagnosing a susceptibility to an ocular disorder, including glaucoma and exfoliation syndrome. The invention provides methods of diagnosing an... |
|
|
US20090325911 |
Use of Androgens for the Treatment of Parkinson's Disease
The invention generally provides therapeutic and prophylactic methods relating to the use of androgens for the treatment of Parkinson's disease or other neurodegenerative diseases. In addition,... |
|
|
US20080020387 |
BIOMARKER-OPTIMIZED ADHD TREATMENT
Methods of predicting patient responsiveness to treatment of attention-deficit/hyperactivity disorder (ADHD) with selective norepinephrine reuptake inhibitors; identifying individuals requiring a... |
|
|
US20100254991 |
Use of Cytokine Expression to Predict Skin Inflammation; Methods of Treatment
Provided are methods for diagnosing the propensity of a subject to develop skin inflammation, in particular, psoriasis. Also provided are methods of treatment with antagonists of IL-17, IL-19,... |
|
|
US20090104620 |
Simplified Method of Determining Predisposition to Scoliosis
The present invention relates to novel genetic markers associated with scoliosis, risk of developing scoliosis and risk of scoliosis curve progression, and simplified methods and materials for... |
|
|
US20090130673 |
Methods for detecting and differentiating mycobacterium genus and mycobacterium avium complex in a sample or culture
The present invention relates to compositions and methods for detecting Mycobacterium genus (Mycobacterium sp.) bacteria (e.g., M. tuberculosis) and M. avium complex (MAC; M. avium, M.... |
|
|
US20060210974 |
Compositions and methods for preventing, treating and diagnosing diabetes
The invention provides methods and compositions for preventing, treating and diagnosing diabetes. |
|
|
US20110065105 |
Novel transcription factor-based biosensor
The present invention provides for a system comprising a BmoR transcription factor, a σ54-RNA polymerase, and a pBMO promoter operatively linked to a reporter gene, wherein the pBMO promoter is... |
|
|
US20100016938 |
DIAGNOSING, MONITORING AND TREATING INFLAMMATION
The present invention provides methods and compositions for treating chronic inflammatory disease in a subject and associated pharmaceutical compositions, medical devices and systems. |
|
|
US20090035284 |
DERIVATION OF NEURAL STEM CELLS FROM EMBRYONIC STEM CELLS AND METHODS OF USE THEREOF
Provided is a method for the derivation of neural stem cells (NSCs) from embryonic stem cells (ESCs) and the use of the NSCs for treatment of various neural disorders. The NSCs that are derived... |
|
|
US20050095592 |
Identification of ovarian cancer tumor markers and therapeutic targets
The present disclosure provides methods for classifying ovarian tumors into BRCA1-type, BRCA2-type or non-BRCA-type tumor types by measuring expression levels of a plurality of disclosed ovarian... |
|
|
US20100062424 |
Assessment of Infectious Bacteria
Disclosed herein are methods for determining whether an opportunistic bacterium is infectious. |
|
|
US20100330066 |
Methods for Use with Baff Antagonists
BAFF plays a central role in acquired immunity. The disclosure identifies BAFF-responsive genes that are substantially upregulated by administration of BAFF and substantially downregulated by... |
|
|
US20070141585 |
Altered gene expression profiles in stable versus acute childhood asthma
Differences in gene expression in control and asthma patients to profile, differentiate, evaluate, etc. patients with exacerbated asthma and stable asthma. |
|
|
US20090264507 |
METHOD OF DIAGNOSING GUM DISEASE-WOUND HEALING USING SINGLE NUCLEOTIDE POLYMORPHISM PROFILES
The present invention provides methods for diagnosing and providing a prognosis for wound healing in a patient by characterizing and analyzing the single nucleotide polymorphism (SNP) of a wound... |
|
|
US20080268430 |
Methods and Kits Pertaining to the Detection, Identification and Quantification of Bacteria and Yeast in Wine, Beer and Juices
The invention concerns new analytical methods for detecting and identifying qualitatively and quantitatively germ contaminations, e.g. bacterial and yeast contaminations usings specific DNA... |
|
|
US20100048687 |
USE OF PHOSPHATASE INHIBITORS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
Provided are novel a target and drugs in the treatment of neurological disorders related to amyloid beta pathology/amyloidosis. More specifically, the use of phosphatase inhibitors for the... |
|
|
US20090131348 |
MICRORNAS DIFFERENTIALLY EXPRESSED IN PANCREATIC DISEASES AND USES THEREOF
The present invention concerns methods and compositions for identifying a miRNA profile for a particular condition, such as pancreatic disease, and using the profile in assessing the condition of... |
|
|
US20090035768 |
Method of Determining Predisposition to Scoliosis and Uses Thereof
The present invention relates to novel genetic markers associated with scoliosis, risk of developing scoliosis and risk of scoliosis curve progression, and methods and materials for determining... |
|
|
US20110010785 |
PRODUCTS AND THEIR USE FOR THE DIAGNOSIS, PREVENTION AND/OR CARE OF HUMAN AND/OR ANIMAL PATHOLOGIES CHARACTERISED BY THE ANOMALOUS DEPOSITION OF B-AMYLOID AND/OR AMYLOID-LIKE SUBSTANCE IN HUMAN AND/OR ANIMAL ORGANS AND TISSUES, AND SCREENING METHOD FOR DETERMINING THE RISK OF SUCH PATHOLOGIES
The patent refers to a screening method carried out on biological material isolated from human and/or animal organisms for determining the risk of human and/or animal pathologies expressing an... |
|
|
US20050208544 |
Diagnostic tests for the detection of peripheral neuropathy
The present invention relates generally to the field of human genetics. Specifically, the present invention relates to methods and materials used to isolate and detect human peripheral neuropathy... |